<div>Drugmaker Biocon Ltd has set the price band for an initial public offering (IPO) of its clinical research services arm, Syngene International Ltd, at 240 rupees to 250 rupees a share, it said on Thursday.</div><div> </div><div>Syngene's IPO shall open for subscription on July 27 and close on July 29, Biocon said in a filing to exchanges.</div><div> </div><div>Biocon said the red herring prospectus filed by Syngene with the Registrar of Companies was approved on 15 July.</div><div> </div><div>The company said in April that it planned to sell 22 million shares and provide an overallotment option.</div>
_20241107190609_original_image_13.webp)
_20241107185854_original_image_29.webp)
